Phoenix, AZ 的 轉移性癌症 臨床試驗
20 項針對 轉移性癌症 的研究正在 Phoenix（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
招募中3 期
- City of Hope, Phoenix
PRE-ISPY Phase I/II Oncology Platform Program
招募中1/2 期
- Mayo Clinic Comprehensive Cancer Center, Phoenix
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
招募中2/3 期
- Mayo Clinic Hospital, Phoenix
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Banner MD Anderson Cancer Center, Phoenix
- Ironwood Cancer & Research Centers, Phoenix
- Mayo Clinic Building- Phoenix, Phoenix
- 還有 1 項
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
招募中1 期
- Mayo Clinic Arizona, Phoenix
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
招募中2 期
- Mayo Clinic Building-Phoenix, Phoenix
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- Mayo Clinic Hospital, Phoenix
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
招募中3 期
- Ironwood Cancer & Research Centers, Phoenix
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
招募中3 期
- HonorHealth, Phoenix
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- Mayo Clinic in Arizona - Phoenix, Phoenix
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
招募中2 期
- Mayo Clinic Arizona, Phoenix
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
招募中1/2 期
- Mayo Clinic Building- Phoenix, Phoenix
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- Banner University Medical Center Phoenix, Phoenix
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Phoenix
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Mayo Clinic, Phoenix
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
招募中1/2 期
- Crinetics Study Site, Phoenix
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
招募中1 期
- Investigative Site #132, Phoenix
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
招募中
- Dignity Health, Phoenix
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
招募中觀察性研究
- Mayo Clinic in Arizona, Phoenix
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors
招募中1/2 期
- Mayo Clinic, Phoenix
其他城市的 轉移性癌症 試驗
- Houston, TX104 項研究
- New York City, NY93 項研究
- Nashville, TN70 項研究
- Boston, MA63 項研究
- Los Angeles, CA57 項研究
- St. Louis, MO54 項研究
- Arlington, VA53 項研究
- Philadelphia, PA46 項研究
- Chicago, IL45 項研究
- San Antonio, TX44 項研究
- Washington, DC43 項研究
- Dallas, TX42 項研究
Phoenix 的其他研究
- 乳癌25 項研究
- 大腸直腸癌25 項研究
- 肥胖症22 項研究
- 非小細胞肺癌20 項研究
- 心臟衰竭18 項研究
- 癌症（所有類型）17 項研究
- 前列腺癌17 項研究
- 心血管疾病16 項研究
- 多發性骨髓瘤16 項研究
- 胰臟癌16 項研究
- 過重15 項研究
- 阿茲海默症15 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。